WHO ICTRP trial

The median effective doses (ED50) of propofol with different doses of…

ChiCTR2000033220 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2000033220
Public title The median effective doses (ED50) of propofol with different doses of dexmedetomidine during hysteroscopic surgery
Scientific title The median effective doses (ED50) of propofol with different doses of dexmedetomidine during hysteroscopic surgery
Primary sponsor Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Observational study
Phase 4
Countries China
Conditions Hysteroscopic surgery
Interventions Control group:normal saline;D0.6 group:0.6ug/kg dexmedetomidine;D0.4 group:0.4ug/kg dexmedetomidine;D0.8 group:0.8ug/kg dexmedetomidine;D0.8 group:1.0ug/kg dexmedetomidine
Registration date May 24, 2020
Target size Control group:30;D0.6 group:30;D0.4 group:30;D0.8 group:30;D0.8 group:30
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations